Role of Immunotherapy in Thymic Malignancies Presented By Heather Wakelee at 2019 ASCO Annual Meeting.

Slides:



Advertisements
Presentaciones similares
Verbs With Spelling Changes in the Present Tense P. 449 Realidades 2.
Advertisements

In both English and Spanish, the verb to be (ser) and numbers are used to tell time. Copyright © 2008 Vista Higher Learning. All rights reserved.
¿Quién es este hombre muy importante? ¿Por qué cada niño en cada escuela de Cuba le conoce?
APL meeting, Rome, Italy. Sept Salvage Therapy with Chemotherapy- or Arsenic Trioxide-based Regimens for Acute Promyelocytic Leukemia in First.
ENCAJE CLÍNICO DE AFLIBERCEPT EN EL CONTEXTO ACTUAL DEL CCRm
Estadio IIIA Abordaje y manejo según el Consenso Argentino
Like other compound tenses you have learned, the future perfect (el futuro perfecto) is formed with a form of haber and the past participle. It is used.
Question words question WORDS? Cómo Cuándo Cuánto Dónde Por qué Qué Cuál Quién A qué hora Adónde.
Copyright © 2008 Vista Higher Learning. All rights reserved. 10.1–1 The future perfect tense (el futuro perfecto) is formed with the future of haber and.
SP1 19/9/11. Hoy: We will learn how to ask about the weather A variety of ways to respond to that question Look at pictures and forecasts and describe.
La Playa Poem based on ‘La Playa’ by Gloria Fuentes.
Desarrolla en serie de Fourier:. Desarrolla en serie de Fourier:
El tiempo Follow the directions in the “notes” section on each slide of this PowerPoint. Save the file with your name and to
By: Señora Pearson translate.com. Spanish Teacher! ¿Qué?
A Mí Me Gusta Mucho. me gusta mucho esquiar y nadar me gusta tocar el piano no me gusta nada ni trabajar ni dibujar A mí.
LOS QUEHACERES DE JORGE
ALC 55 Responde a las preguntas.
La Familia Click to Begin. Hola! Me llamo Juan. This activity is all about mi familia. On each page, read the family member word at the top and then click.
Copyright © 2008 Vista Higher Learning. All rights reserved  Like other compound tenses you have learned, the future perfect (el futuro perfecto)
TENER, ESTAR and ANDAR in the Preterite. The verbs tener, estar, and andar have similar stem changes in the Preterite tense. They all have “uv” in the.
Preposiciones dicen: Donde Each slide will change after a few seconds. For each slide you must decide where the BLACK box is. There are two possible answers.
La comida. Print slides 4-13 to refer to when playing the game. Divide class into 2 teams / families. Have a group of 5 for each team. I usually have.
PERFECT SQUARE SQUARE ROOT NATURAL & WHOLE NUMBERS INTEGERS square root – A square root of a number is a number that, when multiplied by itself, equals.
Subject Pronouns This PowerPoint is animated. Static slides have been appended as hidden slides for printing. Be sure to enable printing of hidden slides.
ALC 62 Jueves el 2 de diciembre All slides are on timer Bring coloring items mañana.
Los Adjetivos Possessivos ¡formas largas y cortas!
P. 330 Realidades 1 Pensar, Querer, and Preferir.
El subjuntivo después de expresiones de duda Subjunctive after expressions of doubt and disbelief Dudo que Uds. no puedan entenderlo.
Los Adjetivos Possessivos
Heidi Ullrich, Senior Director for At-Large
VALORACIÓN DE RESPUESTA EN CPRC METASTÁSICO
Time Flash cards The picture in the background is by Salvador Dalí and is called The Persistence of Memory (1931)
Like other compound tenses you have learned, the future perfect (el futuro perfecto) is formed with a form of haber and the past participle. It is used.
October 21st assignment Read through and practice with this PowerPoint. Ask and discuss it with each other if you have a question. Answer the following.
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC)
Buy Generic Cardura David Ralph, consultant uro-andrologist at St Peter’s Hospital, UCL says, ”Only 5 per cent of men come here with their wives - some.
Like other compound tenses you have learned, the future perfect (el futuro perfecto) is formed with a form of haber and the past participle. It is used.
Haber is an E dropper so it becomes Habr-
Time Flash cards The picture in the background is by Salvador Dalí and is called The Persistence of Memory (1931)
P HASE DIAGRAMS OF PURE SUBSTANCE Roberto Carlos García Zúñiga.
Like other compound tenses you have learned, the future perfect (el futuro perfecto) is formed with a form of haber and the past participle. It is used.
Genentech A Discussion Winter 2018Joseph Milner, RSM54011.
Enhancing Checkpoint Inhibitors in Triple-Negative Breast Cancer Presented By Kevin Kalinsky at 2018 ASCO Annual Meeting.
Haber is an E dropper so it becomes Habr-
In the previous lesson, you learned how to use the subjunctive with expressions of will and influence. You will now learn how to use the subjunctive with.
Conjugate ir in the present tense
Los números.
The Verb TENER.
Page 228 Realidades 1 The Verb TENER.
Para Empezar P. 8 – el reloj p. 8.
Formas y colores.
The Verb Jugar P. 208 Realidades 1.
In the previous lesson, you learned how to use the subjunctive with expressions of will and influence. You will now learn how to use the subjunctive with.
Telling Time in Spanish
1 Use or disclosure of data contained on this sheet is subject to the restriction on the title page of this proposal or quotation. 1 Add a Slide Title.
In both English and Spanish, the verb to be (ser), feminine articles (la/las) and numbers are used to tell time. © by Vista Higher Learning, Inc. All rights.
Hospital Universitario
In the previous lesson, you learned how to use the subjunctive with expressions of will and influence. You will now learn how to use the subjunctive with.
In both English and Spanish, the verb to be (ser) and numbers are used to tell time. © by Vista Higher Learning, Inc. All rights reserved.
Page 228 Realidades 1 Tener, Poner, Hacer.
El Subjuntivo Expressions of Doubt
Hagan Ahora: What verbs mean “to play”? (There are two.)
Page 228 Realidades 1 The Verb TENER.
Page 228 Realidades 1 The Verb TENER.
Resultados de sobrevida a largo plazo en CheckMate 057 y CheckMate 017
Preposiciones y Pronombres
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics,
PRESENTE Y FUTURO DE LA INMUNOTERAPIA EN CÁNCER DE CABEZA Y CUELLO
TERAPIA ADYUVANTE EN MELANOMA DE ALTO RIESGO
Transcripción de la presentación:

Role of Immunotherapy in Thymic Malignancies Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Disclosures Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Overview Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Slide 4 Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Slide 5 Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Slide 6 Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Autoimmunity in TETs Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Autoimmunity in thymic malignancies Presented By Heather Wakelee at 2019 ASCO Annual Meeting

1st line Case Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Chemotherapy – 1st line Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Anthracycline regimens- RR % Presented By Heather Wakelee at 2019 ASCO Annual Meeting

2nd line Case Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Active Agents in TETs Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Positive “Targeted Drug Trials” Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Other novel combinations Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Rhythmic TET Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Slide 17 Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Some ongoing trials Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Immunotherapy in TC Presented By Heather Wakelee at 2019 ASCO Annual Meeting

PD-L1 score and histology correlation Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Slide 21 Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Avelumab: Phase I (Javelin Solid Tumor) Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Prospective Trial all TETs with Pembrolizumab (200 mg q 3 wks) Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Is it worth the risk? Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Slide 25 Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Pembrolizumab Toxicity Presented By Heather Wakelee at 2019 ASCO Annual Meeting

PD-L1 expression and Pembrolizumab Activity Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Other Biomarkers Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Ongoing IO Clinical Trials in TETs Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Conclusions Presented By Heather Wakelee at 2019 ASCO Annual Meeting

Feedback: Política de privacidad Feedback
Do Not Sell My Personal Information
Sobre el proyecto: SlidePlayer Condiciones de uso

© 2025 SlidePlayer.es Inc. All rights reserved.